These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Full remission of acute non-lymphatic leukemia lasting for 16 months following combination therapy with aclacinomycin A]. Beck JD Monatsschr Kinderheilkd; 1986 Aug; 134(8):547-9. PubMed ID: 3464845 [TBL] [Abstract][Full Text] [Related]
7. [Cure of acute myeloblastic leukemia in a child with Down syndrome and tetralogy of Fallot]. Balcar-Boroń A; Nowaczyk-Michalak A; Graduszewska-Czerebiej K Wiad Lek; 1992 Mar; 45(5-6):220-3. PubMed ID: 1455866 [No Abstract] [Full Text] [Related]
8. Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia. Lambertenghi-Deliliers G; Annaloro C; Cortelezzi A; Cortellaro M; Della Volpe A; Maiolo AT; Mozzana R; Pogliani E; Pozzoli E; Polli EE Semin Oncol; 1989 Feb; 16(1 Suppl 2):16-20. PubMed ID: 2928806 [No Abstract] [Full Text] [Related]
9. [Comparative analysis of 3 therapeutic regimens based on the combination of an anthracycline and cytosine arabinoside for remission induction in myeloblastic leukemia]. Sanz MA; Lorenzo JI; Sanz GF; Martín Aragonés G; Rafecas FJ; Martínez JA; Gomis F Sangre (Barc); 1988 Dec; 33(6):497-504. PubMed ID: 3247626 [No Abstract] [Full Text] [Related]
10. Preliminary results of an induction combination regimen including fractionated anthracycline. Krieger O; Bernhart M; Fiedler E; Kasparu H; Weber E; Lutz D Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():66. PubMed ID: 2627610 [No Abstract] [Full Text] [Related]
11. Relapse and death during first remission in acute myeloid leukemia. Yanada M; Garcia-Manero G; Borthakur G; Ravandi F; Kantarjian H; Estey E Haematologica; 2008 Apr; 93(4):633-4. PubMed ID: 18379012 [No Abstract] [Full Text] [Related]
12. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience. Candoni A; Simeone E; Tiribelli M; Malagola M; Russo D; Fanin R Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308 [No Abstract] [Full Text] [Related]
13. [Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide]. Robak T; Krykowski E; Matusewicz W; Brodowski L; Hołub A; Drzewoski J Pol Tyg Lek; 1988 Nov; 43(47):1508-11. PubMed ID: 3075284 [No Abstract] [Full Text] [Related]
14. [HOAP/HOAGP in the treatment of acute non-lymphocytic leukemia: an analysis of 68 cases]. Shan YD Zhonghua Yi Xue Za Zhi; 1985 Oct; 65(10):590-2. PubMed ID: 3938671 [No Abstract] [Full Text] [Related]
16. Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine. Sitar DS; Aoki FY; Bow EJ J Clin Pharmacol; 2008 Aug; 48(8):995-8. PubMed ID: 18495946 [No Abstract] [Full Text] [Related]
17. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group. Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A; J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036 [TBL] [Abstract][Full Text] [Related]
18. Results of the Italian AIEOP/LAM 8204 study for the treatment of childhood AML: an update. Amadori S; Mandelli F; Ceci A; Comelli A; Madon E; Masera G; Nespoli L; Paolucci G; Zanesco L; Defazio D Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():114-5. PubMed ID: 2653484 [No Abstract] [Full Text] [Related]
19. Influence of daunorubicin and cytarabine sequencing on the outcome of therapy in acute myelogenous leukemia: a randomized trial. Archimbaud E; Fiere D; Treille-Ritouet D; Adeleine P; Guyotat D; Sebban C; Vuvan H; Viala JJ Cancer Treat Rep; 1987 Jun; 71(6):571-4. PubMed ID: 3555788 [TBL] [Abstract][Full Text] [Related]
20. [Acute myeloblastic leukemia in adults: evaluation of the AML 06/96 protocol]. Qachouh M; Quessar A; Harif M; Benchekroun S Tunis Med; 2003 Jul; 81(7):461-5. PubMed ID: 14534956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]